Lidocaine Hydrochloride Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing sodium influx that is essential for the generation and propagation of action potentials. By stabilizing the neuronal membrane, it stops nerve signals, resulting in localized numbness and loss of pain perception.

The specific dose and administration schedule are determined by the prescribing clinician based on the procedure, patient characteristics, and route of administration. Healthcare professionals calculate the appropriate amount to achieve effective anesthesia while minimizing toxicity.

Safety data for Lidocaine Hydrochloride in pregnancy and lactation are limited. Clinicians should evaluate the potential benefits against possible risks and consider alternative agents when the safety profile is uncertain. Use only if clearly needed and prescribed by a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and intermediate duration, making it suitable for many procedures. Compared with shorter‑acting agents like procaine, lidocaine offers faster onset and longer analgesia, while having a more favorable safety profile than longer‑acting agents such as bupivacaine, especially regarding cardiotoxicity.

Lidocaine Hydrochloride Noridem should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and avoid freezing. Follow any additional handling instructions provided with the shipment to maintain product integrity.

The drug is supplied as a sterile solution for injection. It can be administered epidurally, intradermally, or intramuscularly by a qualified healthcare professional using aseptic technique. The exact injection site, volume, and concentration are determined by the clinical indication and practitioner judgment.

Serious risks include systemic toxicity leading to central nervous system depression, seizures, or coma, and cardiac arrhythmias such as ventricular tachycardia or heart block. Rare but severe allergic reactions, including anaphylaxis, may also occur. Prompt recognition and supportive management are essential if these events arise.

Patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe hepatic impairment, and individuals with certain cardiac conduction disorders should avoid its use unless a specialist determines that benefits outweigh risks. Contraindications must be assessed by the prescribing clinician.